TerrAscend (TSNDF) FCF Payout Ratio (2022 - 2023)
TerrAscend (TSNDF) reported FCF Payout Ratio of 3.82 for Q4 2023, down 74004.96% year-over-year from N/an in Q4 2022, and down 1410.49% quarter-over-quarter from 0.29 in Q3 2023.
TerrAscend (TSNDF) FCF Payout Ratio (2022 - 2023) Analysis & Trends
TerrAscend (TSNDF) has 2 years of FCF Payout Ratio data on file, last reported at 3.82 in Q4 2023.
- FCF Payout Ratio for Q4 2023 came in at 3.82, down 74004.96% year-over-year; the trailing twelve-month figure through Dec 2023 was 0.15 (changed N/A YoY), and the FY2022 annual result was 0.03, changed N/A from the prior year.
- FCF Payout Ratio slipped to 3.82 in Q4 2023 per TSNDF's latest filing, from 0.29 in the prior quarter.
- Over five years, FCF Payout Ratio peaked at 0.29 in Q3 2023 and troughed at 3.82 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.77 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | TerrAscend | - | - | 34.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -3.82 |
| Sep 30, 2023 | 0.29 |
| Dec 31, 2022 | -0.01 |